CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹41,595 Cr | ₹36,742 Cr | ₹32,130 Cr | ₹29,007 Cr | ₹26,652 Cr |
What is the latest Total Assets ratio of CIPLA ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹41,595 Cr |
| Mar2025 | ₹36,742 Cr |
| Mar2024 | ₹32,130 Cr |
| Mar2023 | ₹29,007 Cr |
| Mar2022 | ₹26,652 Cr |
How is Total Assets of CIPLA Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹41,595 Cr | 13.21 | |
| Mar2025 | ₹36,742 Cr | 14.35 | |
| Mar2024 | ₹32,130 Cr | 10.77 | |
| Mar2023 | ₹29,007 Cr | 8.83 | |
| Mar2022 | ₹26,652 Cr | - | |
Compare Total Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,778.8 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| MANKIND PHARMA | ₹95,911.1 Cr | -1.6% | -4.8% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.6% |
-5.2% |
-11.7% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses